SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Total Debt | ₹4.58 Cr | ₹72 Cr | ₹83 Cr | ₹58 Cr | ₹12 Cr |
What is the latest Total Debt ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹4.58 Cr |
| Mar2024 | ₹72 Cr |
| Mar2023 | ₹83 Cr |
| Mar2022 | ₹58 Cr |
| Mar2017 | ₹12 Cr |
How is Total Debt of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.58 Cr | -93.68 | |
| Mar2024 | ₹72 Cr | -12.86 | |
| Mar2023 | ₹83 Cr | 43.94 | |
| Mar2022 | ₹58 Cr | 364.15 | |
| Mar2017 | ₹12 Cr | - | |
Compare Total Debt of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,283.1 Cr | -5.2% | -1.1% | -16% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| CIPLA | ₹115,641.0 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -5.2% |
-1.1% |
-16% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses